Literature DB >> 2139072

An essential role for constitutive Schiff base-forming ligands in antigen presentation to murine T cell clones.

X M Gao1, J Rhodes.   

Abstract

The role of cell-surface Schiff base-forming ligands in the inductive interaction between class II+ APC and murine T cells was investigated. Schiff bases are produced by the condensation of an amine with the carbonyl group of an aldehyde or ketone in a reversible covalent reaction. Treatment of APC with low concentrations of glutaraldehyde to form Schiff bases on a small proportion of epsilon-amino groups consistently inhibited Ag presentation to primary T cells and T cell clones. Schiff base formation by glutaraldehyde was quantitated by specific reduction with the weak, selective reducing agent sodium cyanoborohydride. Aldehyde inhibition of presentation was observed with allo-, protein, and small peptide Ag, and T cell clones of Th1 and Th2 subtypes were equally susceptible. Large increases in the concentration of glutaraldehyde in brief pretreatments of APC resulted in substantial restoration of Ag-presenting function. Oxidation of T cell sialic acid to produce cell-surface aldehydes resulted in a vigorous proliferative response to class II-positive syngeneic accessory cells. This response was inhibited by preformation of Schiff bases on epsilon-amino groups of the accessory cells by glutaraldehyde. Dose response curves for inhibition of aldehyde-induced and Ag-induced T cell proliferation by glutaraldehyde treatment of accessory cells were similar. Reduction of constitutive aldehydes on cloned T cells by sodium borohydride resulted in inhibition of Ag-specific responses. This took the form of a substantial delay in the time-course of the response consistent with the eventual regeneration of cell-surface aldehydes. Only the presentation of Ag was inhibited. Ongoing established proliferative responses remained unaffected. Together, these data indicate that constitutive Schiff base-forming ligands on APC and T cells are essential in Ag presentation to murine T cells and are consistent with a model of Ag presentation in which reciprocal Schiff base formation is an essential element.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Influence of hypoxia in inflammatory synovitis.

Authors:  T Bodamyali; C R Stevens; M E Billingham; S Ohta; D R Blake
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

Review 2.  Discovery of immunopotentiatory drugs: current and future strategies.

Authors:  J Rhodes
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

3.  Inhibition of specific T-cell activation by monosaccharides is through their reactivity as aldehydes.

Authors:  J Rhodes; B Zheng; M R Lifely
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

Review 4.  Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential.

Authors:  H Chen; J Rhodes
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

5.  Schiff base-mediated co-stimulation primes the T-cell-receptor-dependent calcium signalling pathway in CD4 T cells.

Authors:  S R Hall; J Rhodes
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

6.  Penicillamine and penicillin can generate antigenic determinants on rat peritoneal cells in vitro.

Authors:  C A O'Donnell; A L Foster; J W Coleman
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

7.  Stress-induced modulation of antigen-presenting cell function.

Authors:  A D Rees; Y Donati; G Lombardi; J Lamb; B Polla; R Lechler
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

8.  Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.

Authors:  Alberto Fernández-Tejada; Eric K Chea; Constantine George; Jeffrey R Gardner; Philip O Livingston; Govind Ragupathi; Derek S Tan; David Y Gin
Journal:  Bioorg Med Chem       Date:  2014-09-17       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.